Digital Health Weight Loss Strategies for Weight Loss

Recruiting in Palo Alto (17 mi)

Overseen by Michele L Patel, PhD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Stanford University

No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial tests different ways of using digital tools to track diet, steps, and weight for weight loss in overweight or obese adults. People will use these methods to keep track of their eating and activity over several months. The goal is to find the best combination of tracking methods to help people lose weight effectively.

Research Team

Michele L Patel, PhD

Principal Investigator

Stanford University

Eligibility Criteria

Adults aged 18+ with a BMI of 25.0 to 45.0 kg/m^2, owning a smartphone and willing to use an app for weight loss are eligible. They must speak English, have email access, and be interested in losing weight through behavioral strategies without using weight loss medications or having had bariatric surgery.

Inclusion Criteria

Body mass index (BMI) 25.0 to 45.0 kg/m^2

I am 18 years old or older.

I want to lose weight by changing my behaviors.

Exclusion Criteria

I cannot do moderate exercise like brisk walking.

I have a condition or take medication that makes losing weight difficult or not recommended.

I have not been hospitalized for a mental health condition in the last year.

Treatment Details

Interventions

• Core behavioral weight loss intervention (Behavioural Intervention)
• Self-monitoring diet (Behavioural Intervention)
• Self-monitoring steps (Behavioural Intervention)
• Self-monitoring weight (Behavioural Intervention)

Trial Overview The trial is testing three digital self-monitoring methods for weight loss: tracking diet, steps, and body weight over six months. Participants will receive core treatment remotely and may also get an orientation video to see if it helps with staying in the study.

Participant Groups

Group I: Condition 8 Experimental Treatment 4 Interventions

Core + Track Weight + Track Steps + Track Diet

Group II: Condition 7 Experimental Treatment 3 Interventions

Core + Track Steps + Track Diet

Group III: Condition 6 Experimental Treatment 3 Interventions

Core + Track Weight + Track Diet

Group IV: Condition 5 Experimental Treatment 3 Interventions

Core + Track Weight + Track Steps

Group V: Condition 4 Experimental Treatment 2 Interventions

Core + Track Diet

Group VI: Condition 3 Experimental Treatment 2 Interventions

Core + Track Steps

Group VII: Condition 2 Experimental Treatment 2 Interventions

Core + Track Weight

Group VIII: Condition 1 Experimental Treatment 1 Intervention

Core Only

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Stanford University School of Medicine Stanford, CA

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials

2527

Recruited

17,430,000+

Dr. Richard A. Miller

Stanford University

Chief Executive Officer since 2023

Stanford University, MD

Dr. Robert Schott

Stanford University

Chief Medical Officer since 2021

University of Michigan, MD

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials

2513

Recruited

4,366,000+

Dr. Griffin P. Rodgers

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Chief Executive Officer since 2007

MD, M.A.C.P.

Dr. Griffin P. Rodgers

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Chief Medical Officer since 2007

MD, M.A.C.P.